Tarun Wasil

3.8k total citations · 1 hit paper
18 papers, 2.7k citations indexed

About

Tarun Wasil is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Tarun Wasil has authored 18 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in Tarun Wasil's work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Tarun Wasil is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Tarun Wasil collaborates with scholars based in United States and Italy. Tarun Wasil's co-authors include R. Kanti, Nicholas Chiorazzi, Steven L. Allen, Jonathan E. Kolitz, Manlio Ferrarini, Rajendra N. Damle, Stuart M. Lichtman, Vincent Vinciguerra, Fabio Ghiotto and Angelo Valetto and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Tarun Wasil

17 papers receiving 2.7k citations

Hit Papers

Ig V Gene Mutation Status and CD38 Expression As Novel Pr... 1999 2026 2008 2017 1999 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarun Wasil United States 9 2.5k 1.7k 1.3k 598 349 18 2.7k
Marta Crespo Spain 19 1.5k 0.6× 1.3k 0.8× 925 0.7× 870 1.5× 619 1.8× 52 2.7k
Rajendra N. Damle United States 22 3.9k 1.6× 2.6k 1.5× 2.3k 1.7× 1.0k 1.7× 551 1.6× 53 4.5k
Antonella Zucchetto Italy 23 1.2k 0.5× 862 0.5× 753 0.6× 492 0.8× 307 0.9× 79 1.8k
Ilaria Del Giudice Italy 24 1.5k 0.6× 1.3k 0.8× 764 0.6× 331 0.6× 408 1.2× 82 1.9k
Cheson Bd United States 10 1.5k 0.6× 1.3k 0.8× 788 0.6× 273 0.5× 426 1.2× 59 2.0k
William G. Wierda United States 18 1.8k 0.7× 1.4k 0.8× 948 0.7× 323 0.5× 358 1.0× 44 2.1k
Sarah E. M. Herman United States 19 2.1k 0.9× 1.6k 1.0× 1.0k 0.7× 514 0.9× 504 1.4× 42 2.5k
Stephen E. Spurgeon United States 25 1.6k 0.6× 1.3k 0.8× 549 0.4× 794 1.3× 690 2.0× 98 2.4k
Riccardo Bomben Italy 23 1.1k 0.4× 755 0.5× 628 0.5× 478 0.8× 285 0.8× 72 1.6k
RN Levy United States 6 2.2k 0.9× 1.6k 1.0× 1.2k 0.9× 386 0.6× 317 0.9× 7 2.5k

Countries citing papers authored by Tarun Wasil

Since Specialization
Citations

This map shows the geographic impact of Tarun Wasil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarun Wasil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarun Wasil more than expected).

Fields of papers citing papers by Tarun Wasil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarun Wasil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarun Wasil. The network helps show where Tarun Wasil may publish in the future.

Co-authorship network of co-authors of Tarun Wasil

This figure shows the co-authorship network connecting the top 25 collaborators of Tarun Wasil. A scholar is included among the top collaborators of Tarun Wasil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarun Wasil. Tarun Wasil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kaufman, Matthew, D. Janson, Nancy Driscoll, et al.. (2010). Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia. Medical Oncology. 28(2). 532–538. 7 indexed citations
2.
Bhuiya, Tawfiqul, et al.. (2007). Fine Needle Aspiration of Pulmonary Adiaspiromycosis. Acta Cytologica. 51(2). 217–221. 9 indexed citations
3.
Messmer, Bradley T., Davorka Messmer, Steven L. Allen, et al.. (2005). In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. Journal of Clinical Investigation. 115(3). 755–764. 21 indexed citations
4.
Messmer, Bradley T., Davorka Messmer, Steven L. Allen, et al.. (2005). In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. Journal of Clinical Investigation. 115(3). 755–764. 439 indexed citations
5.
Kay, Neil E. & Tarun Wasil. (2005). Survival of chronic lymphocytic leukemia cells: CD40L and the vascular endothelial growth factor (VEGF) connection. Leukemia. 19(4). 531–532. 3 indexed citations
6.
Wasil, Tarun & Stuart M. Lichtman. (2005). Treatment of Elderly Cancer Patients with Chemotherapy. Cancer Investigation. 23(6). 537–547. 8 indexed citations
7.
Wasil, Tarun, K. R., Emilia Albesiano, et al.. (2005). In B-CLL, time to first treatment is dependant on the IgVH gene mutations and expression of CD38 on leukemic cells. Journal of Clinical Oncology. 23(16_suppl). 6555–6555.
8.
Wasil, Tarun & Stuart M. Lichtman. (2005). Clinical Pharmacology Issues Relevant to the Dosing and Toxicity of Chemotherapy Drugs in the Elderly. The Oncologist. 10(8). 602–612. 41 indexed citations
9.
Kanti, R., Tarun Wasil, Nancy Driscoll, et al.. (2004). Clinical staging and prognostic markers in chronic lymphocytic leukemia. Hematology/Oncology Clinics of North America. 18(4). 795–805. 24 indexed citations
10.
Messmer, Davorka, Tarun Wasil, Bradley T. Messmer, et al.. (2004). Dendritic Cells from Chronic Lymphocytic Leukemia Patients Are Normal Regardless of Ig V Gene Mutation Status. Molecular Medicine. 10(7-12). 96–103. 6 indexed citations
11.
Wasil, Tarun, R. Kanti, & Bhoomi Mehrotra. (2004). The role of monoclonal antibodies in stem cell transplantation. Seminars in Oncology. 31(1). 83–89. 4 indexed citations
12.
Damle, Rajendra N., Franak Batliwalla, Fabio Ghiotto, et al.. (2003). Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood. 103(2). 375–382. 121 indexed citations
13.
Wasil, Tarun & Aby Buchbinder. (2000). Gene Therapy in Human Cancer: Report of Human Clinical Trials. Cancer Investigation. 18(8). 740–746. 4 indexed citations
14.
Wasil, Tarun, Stuart M. Lichtman, Vaibhav Gupta, & Stephen Rush. (2000). Radiation Therapy in Cancer Patients 80 Years of Age and Older. American Journal of Clinical Oncology. 23(5). 526–530. 31 indexed citations
15.
Damle, Rajendra N., Franco Fais, Fabio Ghiotto, et al.. (2000). Chronic lymphocytic leukemia: A proliferation of B cells at two distinct stages of differentiation.. Current topics in microbiology and immunology. 252. 285–292. 7 indexed citations
16.
Damle, Rajendra N., Tarun Wasil, Franco Fais, et al.. (1999). Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia. Blood. 94(6). 1840–1847. 1897 indexed citations breakdown →
17.
Damle, Rajendra N., Tarun Wasil, Franco Fais, et al.. (1999). Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia. Blood. 94(6). 1840–1847. 117 indexed citations
18.
Asnis, Deborah S., et al.. (1996). Probable Transfusion-Associated Graft-Versus-Host Disease in a Patient With Tuberous Sclerosis. Southern Medical Journal. 89(4). 446–448. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026